Home

Remus Pharmaceuticals Ltd PE Ratio

Image

Remus Pharmaceuticals Ltd

NSE: RemusPharma.

PE

65.5

Last updated on: Jan 14, 2025

Key Highlights

  • The P/E Ratio of Remus Pharmaceuticals Ltd is 65.5 as of 14 Jan 25 .
  • The P/E Ratio of Remus Pharmaceuticals Ltd is 47.2 as of March 2024 .
  • The Latest Trading Price of Remus Pharmaceuticals Ltd is ₹ 2198 as of 15 Jan 13:59 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Image

Remus Pharmaceuticals Ltd

NSE: RemusPharma.

PE

47.2

Last updated on: Invalid Date

Company Fundamentals for Remus Pharmaceuticals Ltd

Image

Remus Pharmaceuticals Ltd

NSE: RemusPharma.

Share Price

₹ 2198

-62.65 (-2.77%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Remus Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Remus Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 20252260.65
13 Jan 20252103.85
10 Jan 20252316
09 Jan 20252309.35
08 Jan 20252311.65
07 Jan 20252365.75
06 Jan 20252372.5
03 Jan 20252513.5
02 Jan 20252442.7
01 Jan 20252484.75

SWOT Analysis Of Remus Pharmaceuticals Ltd

Strength

4

che

Weakness

3

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Remus Pharmaceuticals Ltd

Asset Value vs Market Value of Remus Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

PE Ratio of Remus Pharmaceuticals Ltd Explained

``

1331

Market cap

16

Earnings

79.3X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Remus Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Remus Pharmaceuticals Ltd

No data available

* All values are in %

About Remus Pharmaceuticals Ltd

  • Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat.
  • Subsequently, Company converted from a Private to Public and the name of the Company was changed to 'Remus Pharmaceuticals Limited' on January 06, 2023 by the Registrar of Companies, Ahmedabad. The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs.
  • It deals in API (Active Pharmaceutical Ingredient), provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries.
  • The Company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet.

Remus Pharmaceuticals Ltd News Hub

Remus Pharmaceuticals to convene AGM

Remus Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company will be hel

Read more

2024-08-31 00:00:00

Board of Remus Pharmaceuticals recommends interim dividend

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 9

Read more

2024-11-09 00:00:00

Remus Pharmaceuticals to convene board meeting

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 November 202

Read more

2024-11-07 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions